sábado, 7 de noviembre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 28, 2026

Montrose Environmental Group Q4 Earnings Call Highlights

View original at finance.yahoo.com
Montrose Environmental Group Q4 Earnings Call Highlights Montrose Environmental Group logo Key Points Montrose reported a "record" 2025 with revenue of $830.5 million and consolidated adjusted EBITDA of $116.2 million, and set 2026 guidance of $840–$900 million in revenue and $125–$130 million in adjusted EBITDA (imply…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • M&A opportunities identified in testing and consulting across Australia, Canada, and the U.S.

    80% confidence
  • 2025 was the strongest year in the company's history

    80% confidence
  • Organic growth of 12.7% exceeded long-term target of 7% to 9%

    80% confidence
  • Water treatment total addressable market is more than $250 billion

    80% confidence
  • Company is targeting 60% operating cash conversion in 2026, above long-term 50%+ target

    80% confidence
  • Approximately 90% of Montrose's clients operate in private-sector industries and U.S. federal government exposure is less than 3% of revenue

    80% confidence
  • No M&A deals appear imminent in Q1 or early Q2, with potential bolt-on activity more likely in back half of 2026

    80% confidence
  • Remediation and Reuse margins expected to improve in 2026 as water treatment grows and operating leverage increases

    80% confidence
  • Montrose is a water technology business with opportunities broader than PFAS

    80% confidence
  • Company expects to generate approximately $180 million in cumulative operating cash flow across 2025 and 2026

    80% confidence
  • PFAS-related revenue remains about 10% to 15% of the business, with double-digit growth expected into 2026

    80% confidence
  • Recent U.S. EPA methane framework changes are not expected to have a material near-term impact on Montrose's services

    80% confidence
  • Fourth-quarter revenue rose to $193.3 million from $189.1 million a year earlier

    80% confidence
  • Measurement and Analysis margins expected to remain elevated though modestly lower than 2025

    80% confidence
  • Company expects APR segment margins to strengthen in 2026 due to demand, pricing discipline, and operational efficiency

    80% confidence
  • Quarterly margin decline attributed to lower margins in Measurement and Analysis and Remediation and Reuse, plus expenses tied to winding down renewables business

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,996
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,996 hechos verificados con la fuente5,552 documentos fuente archivados
Consulta estos datos → isubstrate.com
Montrose Environmental Group Q4 Earnings Call Highlights — Source | Via News | es.VIA.NEWS